Ismaël Hervé Koumakpayi

Author

Also Known As

I H Koumakpayi, I. H. Koumakpayi, I. Koumakpayi, Ismael H Koumakpayi, Ismael Herve Koumakpayi, Ismael Hervé Koumakpayi, Ismaël Hervé Koumakpayi, Ismaël H. Koumakpayi, Ismaël Hervé Koumakpayi

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Université de Montréal Centre Hospitalier de l’Université de Montréal McGill University Health Centre Centre International de Recherches Médicales de Franceville Hôpital du Sacré-Cœur de Montréal

About

Ismaël Hervé Koumakpayi is an author at Université de Montréal specializing in urology, tumor biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	253
2	Cell Biology	1	1	45
3	Endocrinology	1	1	208
4	Pathology	1	1	208
5	Cancer Genetics	1	1	208

Ismaël Hervé Koumakpayi

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression Luc Furic, Liwei Rong, Ola Larsson, Proceedings of the National Academy of Sciences	2010	512
<i>PTEN</i> genomic deletion is associated with p‐Akt and AR signalling in poorer outcome, hormone refractory prostate cancer Sircar Kanishka, Maisa Yoshimoto, Federico A. Monzon, The Journal of Pathology GeneticsPathologyTumor BiologyTranscriptional RegulationGenitourinary Cancer	2009	208
Expression and Nuclear Localization of ErbB3 in Prostate Cancer Ismaël Hervé Koumakpayi, Jean‐Simon Diallo, Cécile Le Page, Clinical Cancer Research	2006	135
Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients Cécile Le Page, Ismaël Hervé Koumakpayi, Mona Alam‐Fahmy, British Journal of Cancer	2006	89
Integrative Molecular Profiling Reveals Asparagine Synthetase Is a Target in Castration-Resistant Prostate Cancer Kanishka Sircar, Heng Huang, Limei Hu, American Journal Of Pathology UrologyGenitourinary CancerCancer GenomicsCastration-resistant Prostate CancerProstatic Disease	2012	81
EGFR and Her-2 regulate the constitutive activation of NF-kappaB in PC-3 prostate cancer cells Cécile Le Page, Ismaël Hervé Koumakpayi, Laurent Lessard, The Prostate	2005	65
Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-κB signalling pathway and prognostic significance in prostate cancer Ismaël Hervé Koumakpayi, Cécile Le Page, Anne‐Marie Mes‐Masson, British Journal of Cancer	2010	47
The mammalian target of rapamycin pathway is widely activated without <i>PTEN</i> deletion in renal cell carcinoma metastases Tamer Abou Youssif, Mona Fahmy, Ismaël Hervé Koumakpayi, Cancer	2010	47
Gata3 antagonizes cancer progression in Pten-deficient prostates Alana H.T. Nguyen, Mathieu Tremblay, Katharina Haigh, Human Molecular Genetics UrologySignal TransductionSignaling PathwayGata3 Expression LevelsTumor Growth	2013	45
NOXA and PUMA Expression Add to Clinical Markers in Predicting Biochemical Recurrence of Prostate Cancer Patients in a Survival Tree Model Jean‐Simon Diallo, Abdulhadi Aldejmah, Abdelali Filali Mouhim, Clinical Cancer Research	2007	38

Page 1